Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Unchalee Permsuwan

16PUBLICATIONS
11CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedNeurology and neuromuscular diseasesRespiratory diseasesRehabilitation engineeringAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

Sort by Publication Date:
|Feb 19, 2026
Budget Impact of Secukinumab in Psoriatic Arthritis Patients with Contraindication to TNF-Alpha Inhibitors.

Unchalee Permsuwan, Piyameth Dilokthornsakul, Ratree Sawangjit

|Oct 17, 2025
Budget Impact Analysis of Botulinum Toxin Type A for Patients with Severe Blepharospasm in Thailand.

Parima Hirunwiwatkul, Unchalee Permsuwan, Sureerat Ngamkiatphaisan

|Jul 21, 2025
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand.

Unchalee Permsuwan, Krit Leemasawat, Poukwan Arunmanakul

|Apr 21, 2025
Cost-utility analysis of botulinum toxin type A versus oral drug treatment in patients with severe blepharospasm in Thailand.

Parima Hirunwiwatkul, Unchalee Permsuwan, Sureerat Ngamkiatphaisan

|Jun 10, 2024
Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand.

Rungroj Krittayaphong, Unchalee Permsuwan

|Mar 31, 2023
Correction to: Cost-Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand.

Chaicharn Deerochanawong, Rungroj Krittayaphong, Jack Garcia Uranga Romano

Pageof 3

Frequent Collaborators

2 joint publications

Parima Hirunwiwatkul

1 joint publications

Suwaporn Songsermlosakul

1 joint publications

Wanchana Singhan

1 joint publications

Nattawut Wongpraparut

1 joint publications

Sirichai Cheewatanakornkul

1 joint publications

Jirawit Yadee

1 joint publications

Poukwan Arunmanakul

1 joint publications

Niphon Chirapapaisan

1 joint publications

Jiruth Sriratanaban

1 joint publications

Piyameth Dilokthornsakul

Frequent Collaborators

2 joint publications

Parima Hirunwiwatkul

1 joint publications

Suwaporn Songsermlosakul

1 joint publications

Wanchana Singhan

1 joint publications

Nattawut Wongpraparut

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

39.5K
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on : Nov 09, 2016

24.5K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
See more related videos

Top Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

39.5K
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on : Nov 09, 2016

24.5K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
See more related videos